摘要
生物治疗是多发性骨髓瘤(MM)治疗的一条新途径,随着对MM细胞的生物学行为,特别是其与骨髓微环境关系的深入认识,一些新的生物学治疗药物得以设计、研究,对此动态进展作一综述。
出处
《白血病．淋巴瘤》
CAS
2005年第1期47-49,共3页
Journal of Leukemia & Lymphoma
参考文献30
-
1马明信.多发性骨髓瘤的现代治疗[J].白血病．淋巴瘤,2002,11(1):47-48. 被引量：2
-
2Hayashi T, Hideshima, Anderson K C. Novel therapies for multiple myeloma [J]. Brit J Hematol, 2003, 120: 10-17.
-
3Jelinek D F. Mechanism of myeloma cell growth factors [J]. Hematol / Oncol Clin N Amer, 1999, 13:1145-1162.
-
4Chauhan D, Pandey P, Hideshima T, et al.Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF- κ B [J].Blood, 1996, 87:1104-1112.
-
5Dankbar B, Padro T, Leo R, et al. Vascular endotheliar growth factor and interleukin- 6in paracrine tumor- stromal cell interactions in multiple myeloma [J]. Blood,2000, 95:2630-2636.
-
6Gupta D, Treon S P, Shima Y, et al. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endotheliar growth factor secretion: therapeutic applications[J]. Leukemia, 2001, 15:1950-1961.
-
7Podar K, Tai Y T, Davies F E, et al. Vascular endotheliar growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration[J]. Blood, 2001, 98:428 -435.
-
8Davies F E, Rollinson S J, Rawstron A C, et al. High -producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increasing risk of myeloma and have an improved progressionfree survival after treatment[J]. J Clin Oncol,2000, 18:2843-2851.
-
9Hideshima T, Chauhan D, Schlossman R, et al. The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma: therapeutic applications [J]. Oncogene,2001, 20:4519-4527.
-
10Sati H I, Greaves M, Apperley J F, et al. Expression of interleukin 1 - α and tumor necrosis factor- α in plasma cells from patients with multiple myeloma [J]. Brit J Hematol, 1999, 104:350-357.
同被引文献28
-
1于燕霞,石远凯.沙利度胺在恶性肿瘤治疗中的应用[J].癌症进展,2005,3(4):353-359. 被引量：14
-
2姚程,刘峰,姜振宇,康丽花.VAD、M_2和MP化疗方案治疗多发性骨髓瘤的疗效评价[J].吉林大学学报（医学版）,2007,33(1):167-169. 被引量：6
-
3Myeloma Trialist Collaborative Group.Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma:an overview of 6632 patients from 27 randomized trials[J].J Clin Oncol,1998,16:2832～2842.
-
4Attal M,Harousseau JL,Stoppa AM,et al.A pmspective,randomized trial of autologous bone marrwo transplantation and chemotherapy in multiple myeloma[J].N Enggl J Med,1996,335:91～97.
-
5siegel DS,Desikan KR,Mehta J,et al.Age is not a prognostic variable with auto transplants for multiple myeloma[J].Blood,1999,93:51.
-
6Offidani M,Mele A,Corvatta L,et al.Gemeitabinealone or combined with cisplatin in relapsed or refractory multiple myeloma[J].Leuk Lymphoma,2002,43(6):1273～1279.
-
7Aboulafia DM.Thalidomide-based treatment for HIV-aceociated multiple myeloma:a case report[J].MDS Read,2003,13(8):383～389.
-
8Moreau P,Facon T,Attal M,et al.Comparison of 200mg/m^2 melohaant and 8Gy total body irradiation plus 140mg/m^2 melphlan as conditioning regiments for petipheral blood stemcell transplantation in patients with newly diagnosis multiple myeloma:final analysis of the intergroup Francophone du Myeloma 9502 randomized trial[J].Blood,2002,99(3):731.
-
9Barlogie B,Shaughnessy J,Tricot G,et al.Treatment of multiple myeloma[J].Blood,2004,103:20～32.
-
10Attal M,Harousseau J-L,Facon T,et al.Single versus double autologous stem-cell transplantation for multiple myeloma[J].New Engl J Med,2003,349:2495～2502.
二级引证文献1
-
1万鼎铭,王岩,程远东,孙慧,孙玲,谢新生,刘少君,张素平,邵运丽.改良VAD方案治疗多发性骨髓瘤临床疗效观察[J].肿瘤基础与临床,2011,24(1):15-16. 被引量：2
-
1陆建平,王莉,刘崎,王飞,田建明,金爱国,龚建国,曾浩.动态增强磁共振成像诊断肝占位的价值[J].第二军医大学学报,2000,21(6):575-578. 被引量：7
-
2谷晓媛（综述）,林万隆（审校）.恶性肿瘤研究动态[J].世界肿瘤杂志,2010,9(2):130-132. 被引量：1
-
3聂坤荣,李春海,诸亚君.GSTs同工酶与人肺癌的研究动态[J].国外医学（肿瘤学分册）,1992,19(4):196-200.
-
4蒋艳秀,唐仲明.去铁胺抗肿瘤作用研究[J].医药导报,1995,14(2):76-77.
-
5王志才,何杰英.肾癌的研究动态[J].中国综合临床,2000,16(5):325-326.
-
6廖清华.乳癌预后因素的研究动态和进展[J].广西医学,1993,15(5):409-412.
-
7高巍然.多发性骨髓瘤生物学治疗新进展[J].上海医学,2002,25(6):383-384. 被引量：2
-
8梁小波.伊马替尼治疗胃肠道间质瘤研究动态[J].中华普外科手术学杂志（电子版）,2013,7(4):61-62. 被引量：5
-
9张骁,束梅英,张韬.宫颈癌疫苗研究动态[J].中国制药信息,2006,22(12):18-23.
-
10谷晓媛（综述）,林万隆（审校）.恶性肿瘤研究动态[J].世界肿瘤杂志,2010,9(3):198-199.
